Colm J Ryan

23PUBLICATIONS
92CO-AUTHORS
Cancer diagnosisAutomated software engineeringMolecular targetsPhylogeny and comparative analysisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 21, 2026
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

|Jan 19, 2026
nf-core/crisprseq: a versatile pipeline for comprehensive analysis of CRISPR gene editing and screening assays.

Júlia Mir-Pedrol, Laurence Kuhlburger, Marta Sanvicente-García

|Dec 03, 2025
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity.

Thomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose

|Sep 29, 2025
Benchmarking genetic interaction scoring methods for identifying synthetic lethality from combinatorial CRISPR screens.

Hamda Ajmal, Sutanu Nandi, Narod Kebabci

|Sep 11, 2025
Synthetic lethality in cancer drug discovery: challenges and opportunities.

Emanuel Gonçalves, Colm J Ryan, David J Adams

|Jul 04, 2025
The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types.

Pui Ying Chan, Diana Alexander, Ishan Mehta

Pageof 4

Frequent Collaborators

5 joint publications

Stephen Pettitt

3 joint publications

Christopher J Lord

3 joint publications

Emanuel Gonçalves

3 joint publications

Thomas Lefeivre